|
US20020150539A1
(en)
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US5958371A
(en)
*
|
1995-06-08 |
1999-09-28 |
Barnes-Jewish Hospital |
Site specific binding system, nuclear imaging compositions and methods
|
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
|
ATE314097T1
(de)
|
1996-10-28 |
2006-01-15 |
Amersham Health As |
Kontrastmittel
|
|
WO1998018501A2
(en)
*
|
1996-10-28 |
1998-05-07 |
Marsden, John, Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
|
US6261537B1
(en)
|
1996-10-28 |
2001-07-17 |
Nycomed Imaging As |
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
|
|
AU733495B2
(en)
|
1996-10-28 |
2001-05-17 |
Nycomed Imaging As |
Improvements in or relating to diagnostic/therapeutic agents
|
|
EP0991427A2
(en)
*
|
1996-10-28 |
2000-04-12 |
Marsden, John Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
|
WO1998018498A2
(en)
*
|
1996-10-28 |
1998-05-07 |
Marsden, John, Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
|
DE69735901T2
(de)
*
|
1996-10-28 |
2007-05-10 |
Ge Healthcare As |
Verbesseringen an oder in verbindung mit diagnostischen/therapeutischen mitteln
|
|
US20070036722A1
(en)
*
|
1996-10-28 |
2007-02-15 |
Pal Rongved |
Separation processes
|
|
US6331289B1
(en)
|
1996-10-28 |
2001-12-18 |
Nycomed Imaging As |
Targeted diagnostic/therapeutic agents having more than one different vectors
|
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
|
AU7104598A
(en)
*
|
1997-04-09 |
1998-10-30 |
Philipp Lang |
New technique to monitor drug delivery noninvasively (in vivo)
|
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
|
US6416740B1
(en)
*
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
|
JP2003521475A
(ja)
*
|
1999-05-25 |
2003-07-15 |
バーンズ−ジューウィッシュ・ホスピタル |
部位特異的結合系、核画像化組成物及び方法
|
|
EP1192466B1
(en)
*
|
1999-06-23 |
2004-08-11 |
Cornell Research Foundation, Inc. |
Dehydration/rehydration of marked liposomes on a test device
|
|
AU5905400A
(en)
*
|
1999-07-14 |
2001-02-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions for delivery and retention of active agents to lymph nodes
|
|
US7220401B2
(en)
*
|
1999-09-24 |
2007-05-22 |
Barnes-Jewish Hospital |
Blood clot-targeted nanoparticles
|
|
US6576460B1
(en)
|
1999-10-28 |
2003-06-10 |
Cornell Research Foundation, Inc. |
Filtration-detection device and method of use
|
|
US20020103165A1
(en)
*
|
2000-02-29 |
2002-08-01 |
Alliance Pharmaceutical Corp., |
Engineered spray-dried lipid-based microparticles for cellular targeting
|
|
US7141034B2
(en)
|
2000-06-08 |
2006-11-28 |
Altea Therapeutics Corporation |
Transdermal drug delivery device, method of making same and method of using same
|
|
US6676963B1
(en)
*
|
2000-10-27 |
2004-01-13 |
Barnes-Jewish Hospital |
Ligand-targeted emulsions carrying bioactive agents
|
|
US7179449B2
(en)
*
|
2001-01-30 |
2007-02-20 |
Barnes-Jewish Hospital |
Enhanced ultrasound detection with temperature-dependent contrast agents
|
|
US7279150B2
(en)
*
|
2002-01-24 |
2007-10-09 |
Barnes-Jewish Hospital |
Chelating agents with lipophilic carriers
|
|
EP1572639A4
(en)
*
|
2002-01-24 |
2006-08-09 |
Barnes Jewish Hospital |
ON INTEGRIN TARGET MEDIUM FOR IMAGE PRESENTATION
|
|
US6869591B2
(en)
*
|
2002-03-26 |
2005-03-22 |
Barnes-Jewish Hospital |
Paramagnetic particles that provide improved relaxivity
|
|
ATE478337T1
(de)
|
2002-05-31 |
2010-09-15 |
Cornell Res Foundation Inc |
Methoden zum nachweis analyten in proben
|
|
JP2007521254A
(ja)
*
|
2003-06-25 |
2007-08-02 |
ゲルベ |
診断画像用化合物
|
|
CA2534426A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Barnes-Jewish Hospital |
Emulsion particles for imaging and therapy and methods of use thereof
|
|
JP2007511616A
(ja)
*
|
2003-11-19 |
2007-05-10 |
バーンズ−ジューイッシュ ホスピタル |
増強された薬物送達
|
|
WO2005077407A1
(en)
*
|
2004-01-16 |
2005-08-25 |
Barnes-Jewish Hospital |
Targeted atherosclerosis treatment
|
|
CA2560544C
(en)
|
2004-01-16 |
2015-05-19 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
|
AU2005253962A1
(en)
|
2004-06-09 |
2005-12-29 |
Kereos, Inc. |
Lipophilic derivatives of chelate monoamides
|
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
|
WO2006096499A2
(en)
*
|
2005-03-04 |
2006-09-14 |
Washington University |
Mr coronary angiography with a fluorinated nanoparticle contrast agent at 1.5 t
|
|
EP1716870A1
(en)
*
|
2005-04-29 |
2006-11-02 |
Bracco Imaging S.p.A. |
MRI contrast agents endowed with concentration independent responsiveness
|
|
US20070048383A1
(en)
*
|
2005-08-25 |
2007-03-01 |
Helmus Michael N |
Self-assembled endovascular structures
|
|
US20070232909A1
(en)
*
|
2006-03-28 |
2007-10-04 |
Washington University |
Ultrasonic Characterization of Internal Body Conditions Using Information Theoretic Signal Receivers
|
|
WO2007120911A2
(en)
|
2006-04-14 |
2007-10-25 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
|
CA2663115C
(en)
|
2006-09-08 |
2015-04-28 |
Rhode Island Hospital |
Treatment, prevention, and reversal of alcohol-induced liver disease
|
|
WO2008030604A2
(en)
|
2006-09-08 |
2008-03-13 |
Rhode Island Hospital |
Treatment, prevention, and reversal of alcohol-induced brain disease
|
|
EP1938801A1
(en)
|
2006-12-22 |
2008-07-02 |
Biofrontera Bioscience GmbH |
Nanoemulsion
|
|
JP2008162981A
(ja)
*
|
2006-12-28 |
2008-07-17 |
Japan Science & Technology Agency |
ビオチン化ないしホーミングペプチド提示型バイオナノカプセル
|
|
US7646198B2
(en)
*
|
2007-03-09 |
2010-01-12 |
Case Western Reserve University |
Methods for fat signal suppression in magnetic resonance imaging
|
|
FR2914304B1
(fr)
|
2007-03-28 |
2012-11-16 |
Guerbet Sa |
Composes pour le diagnostic de maladies liees a l'expression de vcam.
|
|
FR2914303A1
(fr)
|
2007-03-28 |
2008-10-03 |
Guerbet Sa |
Composes pour le diagnostic de l'apoptose.
|
|
CA2693678C
(en)
|
2007-07-10 |
2017-02-14 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
|
US9468607B2
(en)
|
2007-10-09 |
2016-10-18 |
Washington University |
Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
|
|
CN101868180A
(zh)
|
2007-10-09 |
2010-10-20 |
圣路易斯华盛顿州立大学 |
成像粒子
|
|
EP2112366B1
(en)
|
2008-04-23 |
2011-11-02 |
Magneti Marelli S.p.A. |
Electromagnetic fuel injector for gaseous fuels with anti-wear stop device
|
|
WO2009155335A2
(en)
*
|
2008-06-19 |
2009-12-23 |
University Of Maryland, Baltimore |
Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization
|
|
US9808500B2
(en)
|
2009-12-17 |
2017-11-07 |
Washington University |
Antithrombotic nanoparticle
|
|
US9764043B2
(en)
|
2009-12-17 |
2017-09-19 |
Washington University |
Antithrombotic nanoparticle
|
|
CN103096874A
(zh)
|
2010-04-15 |
2013-05-08 |
华盛顿大学 |
前药组合物、前药纳米粒子及其使用方法
|
|
WO2012159107A1
(en)
|
2011-05-19 |
2012-11-22 |
Rhode Island Hospital |
Inhibition of renal fibrosis
|
|
US9095521B2
(en)
|
2012-02-02 |
2015-08-04 |
Washington University |
Methods for improving muscle strength
|
|
WO2013158265A1
(en)
|
2012-04-20 |
2013-10-24 |
Genelux Corporation |
Imaging methods for oncolytic virus therapy
|
|
EP4321165A3
(en)
|
2013-12-27 |
2024-08-21 |
National University Corporation Tokyo Medical and Dental University |
Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents
|
|
US10213448B2
(en)
|
2016-03-25 |
2019-02-26 |
Novazoi Theranostics |
Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof
|
|
US10987315B1
(en)
|
2018-12-04 |
2021-04-27 |
University Of South Florida |
Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis
|
|
JP7196581B2
(ja)
*
|
2018-12-10 |
2022-12-27 |
大同特殊鋼株式会社 |
被検査材の組織検査方法
|
|
WO2024208433A1
(en)
|
2023-04-06 |
2024-10-10 |
Biofrontera Bioscience Gmbh |
Nanoemulsion without propylene glycol
|
|
WO2024208434A1
(en)
|
2023-04-06 |
2024-10-10 |
Biofrontera Bioscience Gmbh |
Pressurized nanoemulsion
|